Vascular permeability/vascular endothelial growth factors: A potential role in the pathogenesis and treatment of vascular diseases

Vascular Medicine

Volumn 1, Issue 4, 1996, Pages 251-258

  Williams, Bryan ^a,b  

^a UNIVERSITY OF LEICESTER   (United Kingdom)

^b UNIVERSITY OF LEICESTER   (United Kingdom)

Author keywords

Angiogenesis; Endothelium; Growth factors; Vascular endothelial growth factor; Vascular permeability factor

Indexed keywords

VASCULOTROPIN;

ANGIOGENESIS; BLOOD VESSEL PERMEABILITY; HUMAN; PATHOGENESIS; PRIORITY JOURNAL; REVIEW; VASCULAR DISEASE; VASCULAR ENDOTHELIUM;

EID: 0030445824     PISSN: 1358863X     EISSN: None     Source Type: Journal    
DOI: 10.1177/1358863X9600100403     Document Type: Review

References (74)

1. Ross R. The pathogenesis of atherosclerosis: a perspective for the 1990's. Nature 1989; 362: 801-809.
2. Lindner V, Lappi DA, Baird A, Majack RA, Reidy MA. Role of basic fibroblast growth factor in vascular lesion formation. Circ Res 1991; 68: 106-13.
3. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
4. Senger DR, Van De Water L, Brown LF et al. Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer and Metastasis Rev 1993; 12: 303-24.
5. Senger DR, Connolly DT, Van De Water L, Feder J, Dvorak HF. Purification and NH-terminal amino acid sequence of guinea pig tumor-secreted vascular permeability factor. Cancer Res 1990; 50: 1774-78.
6. Senger DR, Galli SJ, Dvorak AM, Perruzzi CA, Harvey VS, Dvorak HF. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science 1983; 219: 983-85.
7. Leung DW, Cachianes G, Kaung WJ, Goeddel DV, Ferrara N. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science 1989; 246: 1306-309.
8. Shweiki D, Itin A, Neufeld G, Gitay-Goren H, Keshet E. Patterns of expression of vascular endothelial growth factor (VEGF) and VEGF receptors in mice suggest a role in hormonally regulated angiogenesis. J Clin Invest 1993; 91: 2235-43.
9. Breier G, Albrecht S, Sterrer S, Risau W. Expression of vascular endothelial growth factor during embryogenic angiogenesis and endothelial cell differentiation. Development 1992; 114: 521-32.
10. Senger DR, Perruzzi CA, Feder J, Dvorak HF. A highly conserved vascular permeability factor secreted by a human and rodent tumor cell lines. Cancer Res 1986; 46: 5629-32.
11. Connolly DT, Olander JV, Heuvelman D et al. Human vascular permeability factor. Isolation from U937 cells. J Biol Chem 1989; 264: 20017-24.
12. Ferrara N, Henzel WJ. Pituitary follicular cells secrete a novel heparin-binding growth factor specific for vascular endothelial cells. Biochem Biophys Res Commun 1989; 161: 851-58.
13. Gospodarowicz D, Abraham JA, Schilling J. Isolation and characterization of a vascular endothelial cell mitogen produced by pituitary-derived folliculo stellate cells. Proc Natl Acad Sci U S A 1989; 86: 7311-15.
14. Plouet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 1989; 8: 3801-806.
15. Tischer E, Mitchell R, Hartman T et al. The human gene for vascular endothelial growth factor. Multiple protein forms are encoded through alternative exon splicing. J Biol Chem 1991; 266: 11947-54.
16. Houck KA, Ferrara N, Winer J, Cachianes G, Li B, Leung DW. The vascular endothelial growth factor family - identification of a fourth molecular species and characterization of alternative splicing of RNA. Mol Endocrinol 1991; 5: 1806-14.
17. Charnock-Jones SD, Sharkey AM, Rajput-Williams J et al. Identification and localization of alternatively spliced mRNAs for vascular endothelial growth factor in human uterus and estrogen regulation in endometrial carcinoma cell lines. Biol Reprod 1993; 48: 1120-28.
18. Keck PJ, Hauser SD, Krivi G et al. Vascular permeability factor, an endothelial cell mitogen related to PDGF. Science 1989; 246: 1309-12.
19. Tischer E, Gospodarowicz D, Mitchell R et al. Vascular endothelial growth factor: a new member of the platelet-derived growth factor gene family. Biochem Biophys Res Commun 1989; 165: 1198-206.
20. Maglione D, Guerriero V, Viglietto G, Delli-Bovi P, Persico MG. Isolation of a human placenta cDNA coding for a protein related to the vascular permeability factor. Proc Natl Acad Sci U S A 1991; 88: 9267-71.
21. Walter P, Blobel GJ. Translocation of proteins across the endoplasmic reticulum. III. Signal receptor protein (SRP) causes signal sequence-dependent and site-specific arrest of chain elongation that is released by microsomal membranes. J Cell Biol 1981; 91: 557.
22. Ferrara N, Leung DW, Cachianes G, Winer J, Henzel WJ. Purification and cloning of vascular endothelial grow th factor secreted by folliculo-stellate cells. Methods Enzymol 1991; 198: 391.
23. Peretz D, Gitay-Goren H, Safran M, Kimmel N, Gospodarowicz D, Neufeld G. Glycosylation of vascular endothelial growth factor is not required for its mitogenic activity. Biochem Biophys Res Commun 1992; 182: 1340-47.
24. Houck KA, Leung DW, Rowland AM, Winer J, Ferrara N. Dual regulation of vascular endothelial growth bioavailability by genetic and proteolytic mechanisms. J Biol Chem 1992; 267: 26031-37.
25. Vaisman N, Gospodarowicz D, Neufeld G. Characterization of the receptors for vascular endothelial growth factor. J Biol Chem 1990; 265: 19461-466.
26. Ferrara N, Winer J, Burton T. Aortic smooth muscle cells express and secrete vascular endothelial growth factor. Growth Factors 1991; 5: 141.
27. Yeo T-K, Senger DR, Dvorak HF, Freter L, Yeo K-T. Glycosylation is essential for efficient secretion but not for the permeability enhancing activity of vascular permeability factor. Biochem Biophys Res Commun 1991; 179: 1568-75.
28. Gitay-Goren H, Soker S, Vlodavsky I, Neufeld G. The binding of vascular endothelial growth factor to its receptors is dependent on cell surface-associated heparin-like molecules. J Biol Chem 1992; 267: 6093-98.
29. Ferrara N, Houck K, Jakeman L, Leung DW. Molecular and biological properties of the vascular endothelial growth factor family of proteins. Endocr Rev 1992; 13: 18-32.
30. Kohn S, Nagy JA, Dvorak HF, Dvorak AM. Pathways of macromolecular tracer transport across venules and small veins. Structural basis for the hyperpermeability of tumor blood vessels. Lab Invest 1992; 67: 596-607.
31. Palade GE. The microvascular endothelium revisited. In: Simionescu N, Simionescu M eds. Endothelial cell biology in health and disease. New York: Plenum Press, 1988: 3-22.
32. Connolly DT, Heuvelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-78.
33. Ploüet J, Schilling J, Gospodarowicz D. Isolation and characterization of a newly identified endothelial cell mitogen produced by AtT-20 cells. EMBO J 1989; 8: 3801.
34. Levy AP, Tamargo R, Brem H, Nathans D. An endothelial cell growth factor from the mouse neuroblastoma cell line NB41. Growth Factors 1989; 2: 9-19.
35. Connolly DT, Hewelman DM, Nelson R et al. Tumor vascular permeability factor stimulates endothelial cell growth and angiogenesis. J Clin Invest 1989; 84: 1470-78.
36. Gross JL, Moscatelli D, Rifkin DB. Increased capillary endothelial cell protease activity in response to angiogenic stimuli. Proc Natl Acad Sci U S A 1983; 80: 2623.
37. Zetter B. Migration of capillary endothelial cells is stimulated by tumour-derived factors. Nature 1979; 285: 42.
38. Folkman J, Haudenshild CC, Zetter BR. Long-term culture of capillary endothelial cells. Proc Natl Acad Sci U S A 1979; 76: 5217.
39. Phillips HS, Hains J, Leung DW, Ferrara N. Vascular endothelial growth factor is expressed in rat corpus luteum. Endocrinology 1990; 127: 965-68.
40. Ravindranath N, Little-Ihrig L, Phillips HS, Ferrara N, Zeleznick E. Vascular endothelial growth factor mRNA expression in the primate ovary. Endocrinology 1992; 131: 254-60.
41. Dvorak HF, Sioussat TM, Brown LF et al. Distribution of vascular permeability factor (vascular endothelial growth factor) in tumors: concentration in tumor blood vessels. J Exp Med 1991; 174: 1275-78.
42. Berkman RA, Merril MJ, Reinhold WC et al. Expression of the vascular permeability factor/vascular endothelial growth factor gene in central nervous system neoplasms. J Clin Invest 1993; 91: 153-59.
43. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-45.
44. Plate KH, Breier G, Weich HA, Risau W. Vascular endothelial growth factor is a potent tumor angiogenesis factor in human gliomas in vivo. Nature 1992; 359: 845-48.
45. Kim KJ, Li B, Winer J et al. Inhibition of vascular endothelial growth factor induced angiogenesis suppresses tumor growth in vivo. Nature 1993; 362: 841-44.
46. 2+ and von Willebrand factor release in human endothelial cells. Am J Pathol 1991; 138: 213-21.
47. Unemori E, Ferrara N, Bauer EA, Amento EP. Vascular endothelial growth factor induces interstitial collagenase expression in human endothelial cells. J Biol Chem (in press).
48. Pepper MS, Ferrara N, Orci L, Montesano R. Vascular endothelial growth factor (VEGF) induces plasminogen activators and plasminogen activator inhibitor 1 in microvascular endothelial cells. Biochem Biophys Res Commun 1991; 181: 902.
49. Pekala P, Marlow M, Heuvelman D, Connolly D. Regulation of hexose transport in aortic endothelial cells by vascular permeability factor and tumor necrosis factor-alpha, but not by insulin. J Biol Chem 1990; 265: 18051-54.
50. Clauss M, Gerlach M, Gerlach H et al. Vascular permeability factor: A tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity and promotes monocyte migration. J Exp Med 1990; 172: 1535-45.
51. Bauters C, Asahara T, Zheung LP et al. Recovery of disturbed endothelium-dependent flow in the collateral-perfused rabbit ischemic hindlimb after administration of vascular endothelial growth factor. Circulation 1995; 91: 2802-809.
52. Shibuya M, Yamaguchi S, Yamane A et al. Nucleotide sequence and expression of a novel human receptor type tyrosine kinase gene (flt) closely related to the fms family. Oncogene 1990; 5: 519-24.
53. Terman BI, Carrion ME, Kovacs E, Rasmussen BA, Eddy RL, Shows TB. Identification of a new endothelial cell growth factor receptor tyrosine kinase. Oncogene 1991; 6: 1677-83.
54. Devries C, Escobedo JA, Ueno H, Houck K, Ferrara N, Williams LT. The fms-like tyrosine kinase, a receptor for vascular endothelial growth factor. Science 1992; 255: 989-91.
55. Matthews W, Jordan CT, Gavin M, Jenkins NA, Copcland NG, Lemischka IR. A receptor tyrosine kinase cDNA isolated from a population of enriched primitive hematopoietic cells and exhibiting close genetic linkage to c-kit. Proc Natl Acad Sci U S A 1991; 88: 9026-30.
56. Oelrichs RB, Reid HH, Bernard O, Ziemiecki A, Wilks AF. NYK/FLK-1 - a putative receptor protein tyrosine kinase isolated from ElO embryonic neuroepithelium is expressed in endothelial cells of the developing embryo. Oncogene 1993; 8: 11-18.
57. Terman BI, Dougher-Vermazen M, Carrion ME et al. Identification of the KDR tyrosine kinase as a receptor for vascular endothelial cell growth factor. Biochem Biophys Res Commun 1992; 187: 1579-86.
58. Milauer B, Wizigmann-Voos S, Martinez R, Moller NPH, Risau W, Ullrich A. High affinity VEGF binding and developmental expression suggest flk-1 as a major regulator of vasculogenesis and angiogenesis. Cell 1993; 72: 835-46.
59. Williams B, Quinn-Baker A, Gallacher B. Serum and platelet-derived growth factor-induced expression of vascular permeability factor mRNA by human vascular smooth muscle cells in vitro. Clin Sci 1995; 88: 141-17.
60. Williams B, Quinn-Baker A, Gallacher B, Lodwick D. Angiotensin II increases vascular permeability factor gene expression by human vascular smooth muscle cells. Hypertension 1995; 25: 913-17.
61. Williams B, Gallacher B, Patel H, Orme C. The potential role of vasopressin as a modulator of endothelial function. In: Saito T, Kurokawa K, Yoshida S eds. Neurohypophysis. Amsterdam: Elsevier, 1995: 573-82.
62. Brogi E, Wu T, Namiki A, Isner JM. Indirect angiogenic cytokines upregulate VEGF and bFGF gene expression in vascular smooth muscle cells, whereas hypoxia upregulates VEGF expression only. Circulation 1994; 90: 649-52.
63. Stavri GT, Zachary IC, Baskerville PA, Martin JF, Erusalimsky JD. Basic fibroblast growth factor upregulates the expression of vascular endothelial growth factor in vascular smooth muscle cells: synergistic interaction with hypoxia. Circulation 1995; 92: 11-14.
64. Shweiki D, Itin A, Soffer D, Keshet E. Vascular endothelial growth factor induced by hypoxia may mediate hypoxia-initiated angiogenesis. Nature 1992; 359: 843-15.
65. Mukhopadhyay D, Tsiokas L, Zhou X-M, Foster D, Brugge JS, Sukhatme VP. Hypoxic induction of human vascular endothelial growth factor expression through c-Src activation. Nature 1995; 375: 577-81.
66. Cohen RA. Dysfunction of vascular endothelium in diabetes mellitus. Circulation 1993; 87(suppl V): V67-V76.
67. Tooke JE. Microcirculation function in human diabetes: A physiological perspective. Diabetes 1995; 44: 721-26.
68. Poston L, Taylor PD. Endothelium-mediated vascular function in insulin-dependent diabetes mellitus. Circ Res 1995; 88: 245-55.
69. Aiello LP, Avery RL, Arrigg PG et al. Vascular endothelial growth factor in ocular fluid of patients with diabetic retinopathy and other retinal disorders. N Engl J Med 1994; 331: 1480-87.
70. Scott-Burden T, Vanhoutte PM. The endothelium as a regulator of vascular smooth muscle proliferation. Circulation 1993; 87(suppl V): 51-55.
71. Fishman JA, Ryan GB, Kamovsky MJ. Endothelial regeneration in the rat carotid artery and the significance of endothelial denudation in the pathogenesis of myointimal thickening. Lab Invest 1975; 32: 339-51.
72. Asahara T, Bauters C, Pastore C et al. Local delivery of vascular endothelial growth factor accelerates reendothelialization and attenuates intimai hyperplasia in balloon-injured rat carotid artery. Circulation 1995; 91: 2793-801.
73. Takeshita S, Zheng LP, Brogi E et al. A single intraarterial bolus of vascular endothelial growth factor augments revascularization in a rabbit ischemic hind limb model. J Clin Invest 1994; 93: 662-70.
74. Isner JM, Walsh K, Symes J et al. Arterial gene therapy for therapeutic angiogenesis in patients with peripheral artery disease. Circulation 1995; 91: 2687-92.